NDC 65250-266-04 Exparel

Bupivacaine

NDC Package Code 65250-266-04

The NDC Code 65250-266-04 is assigned to a package of 4 vial in 1 carton > 20 ml in 1 vial (65250-266-20) of Exparel, a human prescription drug labeled by Pacira Pharmaceuticals Inc.. The product's dosage form is injection, suspension, liposomal and is administered via infiltration form.

Field Name Field Value
NDC Code 65250-266-04
Package Description 4 VIAL in 1 CARTON > 20 mL in 1 VIAL (65250-266-20)
Proprietary Name Exparel What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Non-Proprietary Name Bupivacaine What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
11-Digit NDC Billing Format 65250026604 NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.
Billing Unit ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Product Type Human Prescription Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
Labeler Name Pacira Pharmaceuticals Inc.
Dosage Form Injection, Suspension, Liposomal - A liquid preparation, suitable for injection, which consists of an oil phase dispersed throughout an aqueous phase in such a manner that liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance, either within a lipid bilayer or in an aqueous space) are formed.
Administration Route(s)
  • Infiltration - Administration that results in substances passing into tissue spaces or into cells.
Active Ingredient(s)
  • BUPIVACAINE 13.3 mg/mL
Pharmacological Class(es)
  • Amide Local Anesthetic - [EPC] (Established Pharmacologic Class)
  • Amides - [CS]
  • Local Anesthesia - [PE] (Physiologic Effect)
Sample Package No Sample Package?
This field Indicates whether this package is a sample packaging or not.
Marketing Category NDA - A product marketed under an approved New Drug Application. What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
FDA Application Number NDA022496 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Start Marketing Date 01-01-2012 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.
Listing Expiration Date 12-31-2019 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.

NDC Code Structure

  • 65250 - Pacira Pharmaceuticals Inc.
    • 65250-266 - Exparel
      • 65250-266-04 - 4 VIAL in 1 CARTON

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

NDC HCPCS Crosswalk

This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

NDC 65250-266-04 HCPCS crosswalk information with package details and bill units information.

NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
65250026604C9290Inj, bupivacaine liposome1 MG2042661064

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for Exparel with product NDC 65250-266.

NDC Package CodePackage Description
65250-266-0910 VIAL in 1 CARTON > 20 mL in 1 VIAL (65250-266-20)

* Please review the disclaimer below.

Previous Code
65250-133
Next Code
65255-409